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Bioactivity assessment of additively 
manufactured doped-HA composite scaffolds 
for bone tissue engineering 




Abstract: Composites are promising candidates for treating bone defects, but manufacturing of composite scaffolds is challenging. 
This study aimed to fabricate composite scaffolds based on polycaprolactone (PCL) and doped Hydroxyapatite (HA) via a single step 
melt extrusion additive manufacturing technique. Starting from the raw powder forms, the printed scaffolds were produced and then 
characterized for morphology, mechanical behavior and in vitro mineralization. MicroCT revealed the dispersion of ceramic particles 
in the PCL matrix. Also, SEM showed the ceramic particles on the surfaces of printed scaffolds. Furthermore, bioactivity assays 
confirmed the enhanced apatite deposit formation on composite scaffolds compared to PCL alone. 
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I. Introduction 
Natural bone is a composite of organic (collagen) and 
inorganic (calcium phosphate) materials that in 
combination provide bone with flexibility and load bearing 
properties. The use of composites with adequate 
mechanical properties and bone forming ability (i.e. 
bioactivity) are needed for treating bone defects. PCL has 
been widely investigated for bone tissue applications as it 
is biocompatible, biodegradable and for its good 
processability. However, PCL is hydrophobic and has low 
interaction with surrounding tissues, including low 
bioactivity. Consequently, to enhance the bioactivity of this 
material the combination with calcium phosphates (i.e. HA 
and its doped forms) has been of interest for the research 
community [1]. Doping of HA with Sr & Zn enhances its 
osteogenic potential, Zn also adds anti-bacterial properties 
[2,3]. 
However, the manufacturing of composites is still a 
challenging task. Particularly, solvent dissolution and/or 
filament production are two key steps in the majority of 
biomanufacturing methods, including 3D printing. PCL is 
usually dissolved in a solvent and the ceramic particles are 
suspended to create a composite paste, which is then 
printed, whereas in the powder form polymers and ceramics 
are mixed and subsequently extruded to create material 
coils, before further processing [4]. In this work, a solvent 
free and single-step melt-extrusion process was used to 
manufacture PCL composite scaffolds with tailorable 
bioactive properties and mechanical characteristics.  
II. Materials and methods 
Cylindrical porous composite scaffolds, see Fig 1a, with 
7mm diameter and 0.8 mm inter strand spacing were 
additively manufactured using an EnvisionTEC BioPlotter 
via melt extrusion of raw materials. The composite powders 
containing 10% and 20% w/w of SrHA and ZnHA in PCL 
(Polyscience Europe Ltd) were processed following the 
protocol reported in [1] and 3D scaffolds produced 
according to the conditions reported in Table 1.  











PCL 130 6.0 0.6 
PCL/10SrHA 140 6.2 0.6 
PCL/20SrHA 140 6.5 0.3 
PCL/10ZnHA 140 6.2 0.6 
PCL/20ZnHA 140 6.5 0.3 
 
The bioactive potential of the scaffolds was assessed via the 
in vitro mineralization assay in simulated body fluid (SBF), 
according to Kukubo protocol for 28 days [5]. All the 
scaffolds were individually soaked in 5ml SBF solution and 
stored at 37°C. The solution was changed twice a week and 
the scaffolds collected at each time point were dried 
overnight before further characterization. Surface 
morphology was evaluated by scanning electron 
microscopy (SEM), Hitachi FE-SEM SU5000 microscope 
equipped with energy dispersive X-ray (EDX). The internal 
microstructure of 3D printed scaffolds was characterized by 
Bruker Skyscan1275 micro computed tomography 
(MicroCT) and mechanical behaviour (n=5) via 
compressive tests using an Instron 5500S, equipped with a 
500 N load cell and a constant loading rate of 0.5 mm/min. 
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III. Results and discussion 
The manufacturing process was a single-step approach and 
did not require any post processing. An initial visual 
inspection of the scaffolds was conducted to verify the 
suitability of the printing conditions. MicroCT analysis 
confirmed the microstructure of the additively 
manufactured scaffolds, based on the designed digital file 
and reproducibility of the printing process. The scaffold 
showed a highly inter-connected porous structure as 
reported in the cross-sectional microCT view (see Fig 1b), 
which in addition evidenced the consistent distribution of 
the ceramic particles along each strand (see Fig 1c). Thus, 
proving the effectiveness of the melt extrusion process for 
additively manufacturing PCL composite tissue-like 
substitutes.  
 
Figure 1: Structure of scaffolds. a) CAD model of scaffold. b) 
Cross-sectional view of internal microstructure of composite 
scaffold showing distribution of 10SrHA in PCL polymeric matrix. 
c) Distribution of 10SrHA within the 3D structure. 
The SEM images revealed the presence of the doped HA 
particles on the surfaces of the composites’ scaffolds at day 
0 (see Fig 2), whereas a smoother surface characterized the 
pure PCL scaffolds. Also, the formation of new apatite 
deposits increased on the surface of composite scaffolds 
after soaking in SBF solution for 28 days (Fig 2) in 
comparison to PCL. EDX analysis confirmed the chemical 
composition of the deposits, based primarily on calcium and 
phosphorus. Amongst all the scaffolds the largest apatite 
deposits were observed on PCL/20SrHA scaffolds, 
implying that the addition of 20% w/w of SrHA to PCL 
greatly improved its bioactivity. This is in line with the 
enhanced apatite formation with increasing SrHA content 
observed by previous studies [4]. In relation to the 
mechanical properties, these were found in the range of 
human cancellous bone, even after 28 days in SBF 
immersion, as reported in Table 2. 
IV. Conclusions 
In this study a solvent free manufacturing technique was 
successfully used for the fabrication of PCL composite 
scaffolds with high reproducibility and interconnected 
architecture. All the produced scaffold showed suitable 
mechanical properties for bone tissue applications; 
although, the composite combinations increased the 
bioactive potential of PCL scaffolds by attracting more 
apatite deposition, and with 20SrHA showing most 
profound effect. Further biological evaluation would be 
conducted with the composite scaffolds to confirm their 
bioactive potential in vitro as well as anti-bacterial 
properties. Hence, this manufacturing approach could be 
further investigated to produce patient-specific implants 
with tailorable properties.  
 
 
Figure 2: SEM images of composite scaffolds at different time 
points depicting apatite crystal formation on different compo-
sitions. Scale bars 3µm  
Table 2: Mechanical properties of 3D scaffolds 
Sample Compressive 
Modulus - Day 0 
Compressive 
Modulus - Day 28 
PCL 47.9±2.44 MPa 47.2±3.06 MPa 
PCL/10SrHA 44.2±0.85 MPa 39.3±0.52 MPa 
PCL/10ZnHA 52.2±3.0 MPa 44.4±0.94 MPa 
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